REVOLUTION MEDICINES INC. - COMMON STOCK

Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences

18 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

08 2 2021 16:01:00 提供 Nasdaq GlobeNewswire

Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock

03 2 2021 23:30:00 提供 Nasdaq GlobeNewswire

Revolution Medicines Announces Proposed Public Offering of Common Stock

01 2 2021 16:01:00 提供 Nasdaq GlobeNewswire

Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference

05 1 2021 07:30:00 提供 Nasdaq GlobeNewswire